Although these cancer types (including breast cancer) typically show an increase in CREB3L1 expression, patients with tumors expressing low levels of CREB3L1 may experience a poorer prognosis, as we found for breast cancer (Fig. 7a). Here, CREB3L1 is linked to breast cancer.